MEDTRONIC ($MDT) posted quarterly earnings results on Tuesday, November 18th. The company reported earnings of $1.36 per share, beating estimates of $1.33 by $0.03. The company also reported revenue of $8,961,000,000, beating estimates of $8,953,929,850 by $7,070,150.
You can see Quiver Quantitative's $MDT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MEDTRONIC Insider Trading Activity
MEDTRONIC insiders have traded $MDT stock on the open market 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $MDT stock by insiders over the last 6 months:
- HARRY SKIP KIIL (EVP & President Cardiovascular) has made 0 purchases and 2 sales selling 8,605 shares for an estimated $788,047.
- WILLIAM R JELLISON has made 2 purchases buying 5,000 shares for an estimated $462,750 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MEDTRONIC Hedge Fund Activity
We have seen 1,091 institutional investors add shares of MEDTRONIC stock to their portfolio, and 1,043 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 17,132,581 shares (+48.9%) to their portfolio in Q3 2025, for an estimated $1,631,707,014
- GOLDMAN SACHS GROUP INC removed 9,478,081 shares (-53.7%) from their portfolio in Q3 2025, for an estimated $902,692,434
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 6,935,702 shares (+67.1%) to their portfolio in Q3 2025, for an estimated $660,556,258
- CITADEL ADVISORS LLC removed 6,095,380 shares (-62.2%) from their portfolio in Q3 2025, for an estimated $580,523,991
- CAPITAL RESEARCH GLOBAL INVESTORS removed 5,666,473 shares (-15.6%) from their portfolio in Q3 2025, for an estimated $539,674,888
- UBS GROUP AG added 5,489,720 shares (+96.1%) to their portfolio in Q3 2025, for an estimated $522,840,932
- LONGVIEW PARTNERS (GUERNSEY) LTD removed 5,197,530 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $453,068,690
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MEDTRONIC Congressional Stock Trading
Members of Congress have traded $MDT stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MDT stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 08/14.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
MEDTRONIC Analyst Ratings
Wall Street analysts have issued reports on $MDT in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 10/07/2025
- Argus Research issued a "Buy" rating on 08/26/2025
- Wells Fargo issued a "Overweight" rating on 08/20/2025
- Mizuho issued a "Outperform" rating on 07/16/2025
- Morgan Stanley issued a "Overweight" rating on 07/15/2025
- Leerink Partners issued a "Outperform" rating on 06/16/2025
To track analyst ratings and price targets for MEDTRONIC, check out Quiver Quantitative's $MDT forecast page.
MEDTRONIC Price Targets
Multiple analysts have issued price targets for $MDT recently. We have seen 13 analysts offer price targets for $MDT in the last 6 months, with a median target of $103.0.
Here are some recent targets:
- Robbie Marcus from JP Morgan set a target price of $100.0 on 11/13/2025
- Richard Newitter from Truist Securities set a target price of $103.0 on 10/15/2025
- Rick Wise from Stifel set a target price of $105.0 on 10/09/2025
- Joanne Wuensch from Citigroup set a target price of $112.0 on 10/07/2025
- David Toung from Argus Research set a target price of $115.0 on 08/26/2025
- David Rescott from Baird set a target price of $96.0 on 08/20/2025
- Lee Hambright from Bernstein set a target price of $98.0 on 08/20/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
